AGUIARI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 7.973
AS - Asia 4.331
EU - Europa 3.573
SA - Sud America 639
Continente sconosciuto - Info sul continente non disponibili 159
AF - Africa 105
OC - Oceania 18
Totale 16.798
Nazione #
US - Stati Uniti d'America 7.757
SG - Singapore 1.634
DE - Germania 1.223
CN - Cina 1.019
IT - Italia 792
VN - Vietnam 541
BR - Brasile 498
HK - Hong Kong 354
RU - Federazione Russa 328
UA - Ucraina 266
GB - Regno Unito 247
FI - Finlandia 179
TR - Turchia 179
BD - Bangladesh 133
IN - India 119
FR - Francia 114
SE - Svezia 107
CA - Canada 101
JP - Giappone 99
PL - Polonia 99
MX - Messico 71
ID - Indonesia 67
AR - Argentina 57
NL - Olanda 51
ZA - Sudafrica 43
BE - Belgio 41
IQ - Iraq 35
EC - Ecuador 24
ES - Italia 24
PK - Pakistan 23
CZ - Repubblica Ceca 20
CO - Colombia 19
AT - Austria 17
MA - Marocco 17
LT - Lituania 16
VE - Venezuela 16
AU - Australia 15
MY - Malesia 15
PH - Filippine 12
UZ - Uzbekistan 12
CH - Svizzera 11
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
KR - Corea 9
SA - Arabia Saudita 9
CR - Costa Rica 8
NG - Nigeria 8
ET - Etiopia 7
JO - Giordania 7
RO - Romania 7
TH - Thailandia 7
DK - Danimarca 6
NP - Nepal 6
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
IR - Iran 5
NI - Nicaragua 5
TW - Taiwan 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
KE - Kenya 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
TN - Tunisia 4
BY - Bielorussia 3
GE - Georgia 3
HN - Honduras 3
LV - Lettonia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SV - El Salvador 3
BG - Bulgaria 2
BH - Bahrain 2
DM - Dominica 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
LB - Libano 2
MN - Mongolia 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CV - Capo Verde 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
Totale 16.624
Città #
Ashburn 1.026
Singapore 1.003
Woodbridge 576
San Jose 564
Fairfield 507
Chandler 374
Santa Clara 353
Ann Arbor 346
Hong Kong 343
Beijing 322
Houston 317
Jacksonville 296
Seattle 229
Wilmington 216
Council Bluffs 199
Los Angeles 179
Ho Chi Minh City 177
Cambridge 176
Munich 173
New York 171
Ferrara 150
Hanoi 137
Dallas 132
Tokyo 97
Izmir 95
Warsaw 94
Nanjing 78
Milan 77
Princeton 76
Lauterbourg 69
Buffalo 65
Shanghai 65
San Diego 63
Turku 63
Orem 53
Helsinki 51
São Paulo 44
Boardman 43
Mexico City 43
Jakarta 41
Parma 41
Chicago 40
Denver 39
Rome 39
Tianjin 39
Bologna 37
Brussels 36
London 36
Chennai 34
Stockholm 33
Shenyang 29
Brooklyn 27
Toronto 27
Frankfurt am Main 26
Haiphong 26
Nanchang 26
Bremen 25
Falkenstein 25
Atlanta 24
Montreal 24
Phoenix 24
San Francisco 24
Johannesburg 23
Hefei 22
Trevignano 21
Da Nang 20
Poplar 20
Nuremberg 19
Hebei 18
Manchester 18
San Mateo 18
Addison 17
Rio de Janeiro 17
Amsterdam 16
Boston 16
Moscow 16
Falls Church 15
Mumbai 15
Ottawa 15
Washington 15
Changsha 14
Guangzhou 14
Nervesa della Battaglia 14
Redwood City 14
Belo Horizonte 13
Cassago Brianza 13
Dearborn 13
Kunming 13
New Delhi 13
Ankara 12
Brno 12
Dhaka 12
Jinan 12
Macherio 12
Norwalk 12
Philadelphia 12
Verona 12
Jiaxing 11
Quinto di Treviso 11
Zhengzhou 11
Totale 10.335
Nome #
Berberine slows cell growth in autosomal dominant polycystic kidney disease cells 292
The activation of mTOR independent autophagy in kidney carcinoma cells by the upregulation of miR501-5p occurs through the decrease of mitochondrial calcium uptake 289
Drug repurposing and transposable elements: a new promising strategy to fight prostate cancer 284
Analysis of published PKD1 gene sequence variants 279
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 276
Autosomal dominant polycystic kidney disease linked to PKD2 locus in a family with severe extrarenal manifestations 270
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 270
Cis element "decoy"against the upstream promoter of the human estrogen receptor gene 267
INHIBITION OF AUTOPHAGY INCREASES THE RESPONSE TO SUNITINIB IN CCRCC CELL LINES 260
Role of calcium in polycystic kidney disease: From signaling to pathology 253
MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells 244
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 243
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 238
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 238
Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene 233
miR-501 overexpression in renal carcinomas 230
In vitro stability of polymerase chain reaction-generated DNA fragments in serum and cell extracts 230
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 228
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 224
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 221
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 219
Somatic and germline variants affect prognosis and susceptibility in prostate cancer 218
Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells 216
Nonspecific cation current associated with native polycystin-2 in HEK-293 cells 216
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells 215
Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: Expression of mutated genes 214
Androgen responsiveness and androgen receptor gene expression in human kidney cells in continuous culture 211
Effects of a hydroxyapatite-based biomaterial on gene expression in osteoblast-like cells 207
Multidrug therapy for polycystic kidney disease: a review and perspective 203
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 203
The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells 202
Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism. 198
Il Registro Italiano del Rene Policistico Autosomico Dominante 197
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 197
K562 erytrhoid and HL60 macrophage differentiation down regulates polycystin, a large membrane associated protein 196
Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer 195
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 194
THE INHIBITION OF AUTOPHAGY INCREASES SUNITINIB RESPONSE IN KIDNEY CANCER CELLS 192
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 192
LOH of Chromosome 6q compared with LOH of 17q and 18q in ovarian cancers: relationship to p53 expression and clinicopahological findings 192
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 192
Calcium homeostasis and polycystin expression in t-lynphoblasts of ADPKD patients 192
Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. 191
Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions 189
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 184
A native voltage-dependent non selective cation current in HEK-293 cells 182
Modulation of estrogen receptor gene expression in human breast cancer cells: A decoy strategy with specific PCR-generated DNA fragments 182
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 179
Inhibitory effect of dihydrotestosterone on human thyroid cell growth 177
Role of the miR-501 in Renal Carcinomas 177
Autophagy suppression potentiates the sunitinib-dependent inhibition of cell growth and migration in kidney carcinoma cells 175
Detection of disease-causing mutations in prostate cancer by NGS sequencing 175
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 174
A COMBINATION OF TYROSINE KINASE AND AUTOPHAGY INHIBITORS STRENGHTHENS THE INHIBITION OF ANGIOGENIC PATHWAY IN KIDNEY CARCINOMA CELL LINES 173
Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance 168
MicroRNA501-5p activating the mTOR independent autophagy induces p53 degradation in kidney cancer cells 167
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 163
MicroRNA501 may affect the aggressiveness of clear cell renal carcinoma 162
Direct transfection of PCR- generated DNA fragments into mammalian cells employing ethidium bromide indicator and ultrafiltration 161
Regulatory RNAs of the Transglutaminase 2 gene interfere with its expression in leukaemic cell lines after ATRA treatment 156
Polycystin-1 promotes PKC alpha-mediated NF-kappa B activation in kidney cells 151
Inhibition of autophagy reduces cell proliferation and migration by P53 restoring in ccRCC cells 150
Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene 144
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 143
null 138
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 136
MICRORNA501 UP-REGULATION MAY INCREASE THE AGGRESSIVENESS OF CLEAR CELL RENAL CARCINOMA THROUGH MTOR ACTIVATION AND P53 DEGRADATION 136
The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective 130
Suppression of pkhd1 impairs survival in cultured kidney tubular cells. 127
Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma 126
null 126
Autophagy inhibition potentiates anti-cancer activity of Sunitinib in kidney cancer cells 122
State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells 119
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. 118
null 113
Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy 113
null 111
null 107
NF-kB activation is required for apoptosis in fibrocystin7polyductin-depleted kidney epithelial cells 106
null 103
null 102
Molecular Mechanisms of Drug Resistance in Clear Cell Renal Cell Carcinoma 101
THE AUTOPHAGY INHIBITOR DESMETHYLCLOMIPRAMINE REDUCES EPITHELIAL–MESENCHYMAL TRANSITION, PROLIFERATION, AND INVASION IN KIDNEY CARCINOMA CELL LINES 99
null 99
The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca2+-dependent pathway(s) 97
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 96
New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future. 94
null 94
Transglutaminase-2 inhibition restores P53 expression preventing its degradation by autophagic pathway in ccRCC cells 92
MICRORNA501-5P INCREASES AUTOPHAGY IN CLEAR CELL RENAL CELL CARCINOMA 89
Clinical Practice and Prognostic Molecular Biomarkers in Clear Cell Renal Cell Carcinoma: Latest Advancements 85
The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines 85
null 79
MicroRNAs in clear cell renal cell carcinoma: biological functions and applications 72
Expression of polycystin-1 C-terminal fragment enhances the ATP-induced Ca2+ release in human kidney cells 72
The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update 67
null 64
Expression of protein fragments from the human PKD1 gene and production of rabbit polyclonal antibodies to the recombinant proteins. 63
THE EXOGENOUS EXPRESSION OF P53 SUPPRESSES HIF1 ALPHA AND DEACTIVATES VEGF RECEPTOR IN A MECHANISM INVOLVING MDM2 IN KIDNEY CANCER CELLS 50
MicroRNAs and predicted targets in the switch from monolayered to spheroids of cholangiocarcinoma cells 8
Totale 16.792
Categoria #
all - tutte 69.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022731 0 86 53 37 48 21 40 48 24 62 73 239
2022/2023896 91 66 33 120 119 138 45 73 115 11 48 37
2023/2024656 41 51 24 23 76 101 40 25 9 18 18 230
2024/20252.413 91 127 204 154 253 219 69 116 326 239 353 262
2025/20266.536 623 238 523 801 1.058 447 815 325 561 682 297 166
2026/2027380 176 204 0 0 0 0 0 0 0 0 0 0
Totale 16.798